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Summary
Background Understanding of the factors driving global antimicrobial resistance is limited. We analysed antimicrobial 
resistance and antibiotic consumption worldwide versus many potential contributing factors.
Methods 
 
Using three sources of data (ResistanceMap, the WHO 2014 report on antimicrobial resistance, and 
contemporary publications), we created two global indices of antimicrobial resistance for 103 countries using data 
from 2008 to 2014: resistance—the global average prevalence of bacteria that were resistant to Escherichia coli E coli 
third-generation cephalosporins and ﬂuoroquinolones, and aggregate resistance—the combined average prevalence 
of 
 
and 
 
E coli Klebsiella 
 
spp resistant to third-generation cephalosporins, ﬂuoroquinolones, and carbapenems, and 
meticillin-resistant 
 
Staphylococcus aureus. Antibiotic consumption data were obtained from the IQVIA MIDAS 
database. The World Bank DataBank was used to obtain data for governance, education, gross domestic product 
(GDP) per capita, health-care spending, and community infrastructure (eg, sanitation). A corruption index was 
derived using data from Transparency International. We examined associations between antimicrobial resistance and 
potential contributing factors using simple correlation for a univariate analysis and a logistic regression model for a 
multivariable analysis.
Findings 
 
In the univariate analysis, GDP per capita, education, infrastructure, public health-care spending, and 
antibiotic consumption were all inversely correlated with the two antimicrobial resistance indices, whereas higher 
temperatures, poorer governance, and the ratio of private to public health expenditure were positively correlated. In 
the multivariable regression analysis (conﬁned to the 73 countries for which antibiotic consumption data were 
available) considering the eect of changes in indices on resistance ( ² 0·54) and aggregate resistance ² 0·E coli R (R 75), 
better infrastructure (p=0·014 and p=0·0052) and better governance (p=0·025 and p<0·0001) were associated 
with lower antimicrobial resistance indices. Antibiotic consumption was not signiﬁcantly associated with either 
antimicrobial resistance index in the multivariable analysis (p=0·64 and p=0·070).
Interpretation 
 
Reduction of antibiotic consumption will not be sucient to control antimicrobial resistance because 
contagion—the spread of resistant strains and resistance genes—seems to be the dominant contributing factor. 
Improving sanitation, increasing access to clean water, and ensuring good governance, as well as increasing public 
health-care expenditure and better regulating the private health sector are all necessary to reduce global antimicrobial 
resistance.
Funding None.
Copyright 
 
© 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
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Introduction
Antimicrobial resistance is a substantial global problem 
across countries regardless of income level and imposes 
a large clinical and ﬁnancial burden.1–3  Multidrug-
resistant bacteria that develop in any country or region 
have been shown to spread rapidly,4,5  and antimicrobial 
resistance is recognised as a so-called One Health 
 
problem.6,7  Although the use and overuse of antibiotics 
are primary drivers of the emergence and maintenance 
of antimicrobial resistance, other factors contribute to 
its increased prevalence.4,5,7–9  The observation of higher 
antimicrobial resistance rates in several low-income 
countries and middle-income countries (LMICs), in 
which per-person consumption of antibiotics is much 
lower than in high-income countries, supports this 
idea.8,10,11  Quality of governance, public spending on 
health, poverty (ie, gross domestic product [GDP] per 
person), education, and community infrastructure are 
known to aect health outcomes.12–14  However, pre-
vious studies have been limited in their assessment of 
antimicrobial resistance and have not been extrapo-
lated to a global scale. Similarly, little is known about 
the eect of climate on the prevalence of antimicrobial 
resistance.
The dissemination of antimicrobial resistance can be 
described as a two-step process. First, de-novo mutations 
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or acquisition of resistance genes, or both, occurs 
 
via 
mobile genetic elements, such as plasmids mediat-
ing an antimicrobial-resistance phenotype. Second, 
 
antimicrobial resistance contagion—the spread of re-
sistant strains—proceeds via several vectors (eg, human 
beings, insects, birds, agriculture, and water).4,5,9  Selec-
tion pressure caused by antibiotic consumption is an 
important primary factor not only for the de-novo 
emergence of antimicrobial resistance but also for 
the selective multiplication of resistant bacteria.15–19 
Reducing inappropriate antibiotic consumption is 
 
a recognised policy priority, and substantial eorts 
are focused on controlling antibiotic usage volumes 
in hospitals, the community, and the agricultural 
sector.1–3,16,18–20 Although antibiotic usage has been shown 
to be an important driver for increasing antimicrobial 
resistance levels, the spread of resistant bacteria or the 
genes that encode for resistance are likely to be much 
more important in the dissemination and prevalence 
of antimicrobial resistance.4,5,9,16,21 
 
The 
 
environment
(including transmission via water, insects, animals, 
and birds) plays an underappreciated part in the 
development and spread of resistant bacteria.4  Another 
driver associated with increased resistance levels is 
poor governance (or corruption). In Europe, poor 
governance and corruption have been shown to be as 
closely associated with dierences in antimicrobial 
resistance levels between countries as are antibiotic 
consumption patterns.22
Most research on antimicrobial resistance has focused 
on data-rich, high-income countries. However, the 
quality of the physical infrastructure and health systems 
in high-income countries has converged to such an 
extent that there is insucient contrast in data to identify 
easily how variations in social, physical, and econo-
mic environments aect antimicrobial resistance. The 
variations across countries in a global antimicrobial 
resistance dataset provide an opportunity to estimate 
the importance of contagion for variations in anti-
microbial resistance levels because low income is 
typically associated with poor water quality and sanita-
tion, overcrowded housing, and inadequate practices to 
prevent infection.
The One Health multifaceted nature of antimicro-
bial resistance suggests the need to understand the 
relative importance of antibiotic consumption as the 
driver for the evolution of resistance versus the many 
other contributing factors that favour contagion. In 
this study, we examined antimicrobial resistance 
levels against countries’ quality of governance, public 
spending on health, education, income, community 
infrastructure, climate, and antibiotic usage volumes 
with speciﬁc antimicrobial-resistance indicators across 
the world.
Research in context
Evidence before this study
Although the use and overuse of antibiotics 
 
are primary drivers 
for the emergence and maintenance 
 
of antimicrobial resistance, 
many other factors also probably contribute 
 
to this problem. 
Quality of governance, public spending 
 
on health, poverty, 
education, and community infrastructure are known to aﬀect 
health outcomes and 
 
therefore will also likely aﬀect antimicrobial 
resistance. 
 
We searched PubMed for articles published from 
Jan 1, 2000, to 
 
Aug 1, 2018, and restricted our search 
 
to articles 
 
published in English. 
 
We excluded all articles relating 
 
to 
tuberculosis, HIV, malaria, and 
 
other parasitic diseases. Using 
 
the 
following combination of 
 
terms, we found the following number 
of articles: “global antimicrobial resistance and corruption” 
(n=1), “global antimicrobial resistance and sanitation” (n=49), 
“global antimicrobial resistance and governance” (n=27), 
“global antimicrobial resistance and infrastructure” (n=29), 
“global antimicrobial resistance and poverty” (n=23), “global 
antimicrobial resistance and consumption” (n=389), “global 
antimicrobial resistance and univariate analysis” (n=9), 
and “global antimicrobial resistance and multivariate analysis” 
(n=61). Assessing 
 
these positive hits, none have undertaken a 
global analysis on 
 
the above risk factors using univariate and 
multivariate analysis. 
Added value of 
 
this study
We 
 
used 
 
three diﬀerent sources (ResistanceMap, 
 
WHO 2014 
report on antimicrobial resistance, and contemporary 
publications) to ﬁnd global 
 
data on reported antimicrobial 
resistance levels. 
 
We created two global antimicrobial resistance 
measures: resistance and aggregate resistance. Escherichia coli 
Antibiotic consumption data were obtained 
 
from the IQVIA 
MIDAS database (Danbury, 
 
CT, 
 
USA). 
 
The World Bank DataBank 
was used for 
 
data for governance, education, gross domestic 
product per person, health-care spending, and community 
infrastructure (eg, sanitation). 
 
We derived a corruption index 
using data from Transparency International (Berlin, Germany). 
Associations were examined 
 
using simple correlations for 
univariate analysis and a logistic regression model for 
multivariable analysis.
Implications of all 
 
the available evidence
Multivariate analysis showed that better infrastructure and 
governance were signiﬁcantly associated 
 
with lower measures 
of antimicrobial resistance, but that antibiotic consumption 
was not signiﬁcantly associated with higher antimicrobial 
resistance. Reducing antibiotic consumption will not be 
suﬃcient to control antimicrobial resistance because 
contagion—the spread of resistant strains—seems 
 
to be the 
dominant factor. Improving sanitation, increasing access to 
clean water, ensuring good governance, plus increasing public 
health-care expenditure all need to be addressed 
 
to reduce 
global antimicrobial resistance.
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Methods
Study design and data sources
We created a dataset on antimicrobial resistance for 
 
103 countries using data from 2008 to 2013 and a second 
dataset on antibiotic consumption for 69 of those countries 
using data from 2014 (see for a complete list of appendix 
 
countries and associated data and sources). Antimicro-
bial resistance data were obtained from three sources: 
ResistanceMap, a global repository of antibiotic resistance 
data from quality-assured and accredited hospitals and 
laboratory networks for 2014;1 the WHO 2014 global report 
on antimicrobial resistance;17  and contemporary pub-
lications on studies of ﬂuoroquinolone resistance in 
Escherichia coli ( ).appendix
Antibiotic consumption data were obtained from the 
IQVIA MIDAS database (Danbury, CT, USA) for 2014 for 
73 countries10 and used for our correlations. Global data 
from 2004 for 63 countries were available to be used for a 
separate analysis replicating the regression analysis 
(appendix).23  We used the World Bank’s DataBank for 
data on governance, education, GDP per person, health-
care spending, community infrastructure, and climate 
indicators 
 
for all included countries.24  Data from 
Transparency International (Berlin, Germany) were used 
for variables on corruption.25
Because there are many possible contributing factors 
aecting antimicrobial resistance and international data 
coverage of all factors is incomplete, we summarised the 
data using indices that capture the main probable 
inﬂuences. 
 
Six indices were created from the available 
measures (ie, the raw data)—ie, governance, education, 
GDP per person, health expenditure, infrastructure, and 
climate ( 1)—and these were compared with levels of 
 
table 
 
antimicrobial resistance and consumption.
The index covariates each have a mean of 0 and an 
SD of 1 when taken across available data from the 
103 countries considered for this study (appendix). These 
indices were formed in three steps. First, each measure (or 
raw data variable) for each country was standardised by 
subtracting its overall mean and then dividing by the 
overall SD. Second, for each country, an average of the 
standardised variables within each index was calculated. 
For example, the governance (corruption) index was the 
average of the standardised variables for the 2012 and 2015 
corruption indices, the political stability and absence of 
violence index, and the rule of law index. Data were not 
uniformly available for all countries for all variables. The 
SD of the variables formed in the second step was not 1, 
therefore the ﬁnal step was to divide the variables created 
in step 2 for each country by their own SDs.
Statistical analysis
To study the association between antimicrobial resistance 
and the covariates, we created two country-level measures 
of antimicrobial resistance: the average prevalence of 
resistance of to third-generation cephalosporins E coli 
WHO resistance data, ResistanceMap data, and additional 
data from other published sources (appendix); and the 
average resistance prevalence of spp, E coli, 
 
Klebsiella 
 
and 
 
Staphylococcus aureus, collectively termed aggregate 
resistance, based on WHO data, ResistanceMap data, and 
other data (appendix) Aggregate resistance included data . 
on 
 
and E coli Klebsiella 
 
spp resistance to third-generation 
cephalosporins, ﬂuoroquinolones, and carbapenems, and 
meticillin-resistant 
 
S aureus. Univariate analyses were 
reported with the correlation coecient r.
Regression models were ﬁtted to the data to identify the 
factors that most aected antibiotic resistance across a 
range of countries. We describe the ﬁt of each model using 
 
the coecient of determination ². The explanatory R
variables are the indices described earlier, along with 
See for appendixOnline 
Countries 
with available 
data
Mean (SD) 
 
Maximum 
 
Minimum
Governance
Corruption, 2012 
 
103 
 
47·5 (20·1) 
 
90·0 
 
13·0
Corruption, 2015 
 
103 
 
48·0 (20·5) 
 
91·0 
 
12·0
Political stability and absence of violence 
 
103 
 
–0·1 (1·0) 
 
1·5 
 
–2·9
Rule of law (World Justice Project) 
 
73 
 
0·6 (0·2) 
 
0·9 
 
0·3
Education
Literacy (Nationmaster data, 2003) 
 
103 
 
87·2% (16·6) 
 
100·0% 
 
21·8%
Literacy (average of male and female rates) 
 
103 
 
89·3% (15·1) 
 
100·0% 
 
29·9%
Ratio of female 
 
to male literacy 
 
103 
 
0·9 (0·1) 
 
1·3 
 
0·5
Female literacy 
 
103 
 
87·2% (18·1) 
 
100·0% 
 
21·8%
Male literacy 
 
103 
 
91·4% (12·5) 
 
100·0% 
 
38·0%
Percentage ﬁnishing secondary education 
(2014)
79 
 
78·4% (19·9) 
 
99·6% 
 
13·6%
Primary school completion rate 
 
97 
 
95·3% (10·6) 
 
100·0% 
 
44·4%
GDP per capita, 2015 (purchasing power 
parity in 2011, US$)
103 
 
58123 903 
 
(19 897) 
 
93 900 
 
Health
Health expenditure, total (percentage 
of GDP)
103 
 
7·2% (2·7) 
 
17·1% 
 
2·3%
Ratio of public 
 
to private public health 
expenditure
103 
 
0·8 (0·7) 
 
3·7 
 
0·0
Climate
Average temperature (°C) 
 
103 
 
16·2 (8·5) 
 
28·3 
 
–5·4
Average precipitation (mm per 
 
year) 
 
103 
 
1125·3 (768·9) 
 
3240·0 
 
51·0
Infrastructure
Urbanisation (percentage of population) 
 
103 
 
63·3% (23·5) 
 
100·0% 
 
8·8%
Adequate sanitation, 2015 (percentage of 
population)
103 
 
82·4% (23·2) 
 
100·0% 
 
18·9%
Access to electricity (percentage 
 
of 
population)
103 
 
88·7% (24·1) 
 
100·0% 
 
7·0%
Access to improved 
 
water source 
(percentage of population)
103 
 
92·7% (11·6) 
 
100·0% 
 
40·0%
Internet penetration (percentage of 
population)
103 
 
54·9% (27·8) 
 
98·2% 
 
1·4%
GDP=gross domestic product.
Table 1: Indices and measures
19/09/2018, 13*34Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis
Page 4 of 9https://reader.elsevier.com/reader/sd/pii/S2542519618301864?…6B2933ED856E331F789B830993E71ADCF874C2F1B6092FFEC69694106B9
www.thelancet.com/planetary-health 
 
Vol 2 
 
September 2018 e400
and ﬂuoroquinolones, termed resistance, based on E coli available data on antibiotic usage. Explanatory variables are 
Articles
denoted by an in the below. Resistance was x 
 
equation 
 
measured in percentage points and could vary from 
0 to 100. In the regression model, the dependent variable 
was deﬁned as the logarithm of the odds ratio (OR) of the 
resistance rate to the non-resistance rate. This equation 
form is often referred to as a logit model, and it ensured 
that the modelled predicted resistance rates fell between 
0 and 100:
In this form the βs are interpreted as the percentage change 
in the OR for a unit change in the explanatory variable. To 
 
express the results of the regression in more familiar 
terminology, we used the partial derivative with respect 
to each explanatory variable to show the eect on resist-
ance of a unit increase in the explanatory variable:
depended on the rate of resistance at the point the 
calculation was made. The usual practice is to report 
the eect at the mean of the data.
Although the logit formulation is conceptually pre-
ferred, the statistical results are similar when the de-
pendent variable is modelled as simply resistance 
(linear). This ﬁnding increased our conﬁdence in the 
robustness of the ﬁndings. Both regression model results 
are in the appendix. Models were estimated using 
Epi InfoTM, English language version 7.2.2.1.
Role of 
 
the funding source
There was no speciﬁc funding for this project. The corres-
ponding author had full access to all the data in the study 
and had ﬁnal responsibility for the decision to submit for 
publication.
Results
The mean prevalence of antimicrobial resistance for the 
dependent variable resistance was 29·4% (SD 18·7) E coli 
and for aggregate resistance was 29·6% (15·0). Data for 
E coli resistance were available for 103 countries, whereas 
data for aggregate resistance were available for 73 countries 
(appendix 1). Data for most measures were available 
for 103 countries except for rule of law (available for 
73 countries), percentage of population ﬁnishing secondary 
education (79 countries), and percentage of population 
completing primary school (97 countries). Multivariable 
regression analysis was conﬁned to the 73 countries for 
which antibiotic consumption data were available.
All measures of improved governance (lower corruption, 
political stability, rule of law, and absence of violence) and 
all measures of improved infrastructure (sanitation, safe 
water, internet accessibility, urbanisation, and access to 
electricity) were strongly and inversely correlated with both 
antimicrobial resistance datasets, as was higher GDP per 
person (appendix). By contrast, all measures of education 
(national literacy, average of male and female literacy, ratio 
of female to male literacy, male literacy, female literacy, and 
 
secondary education) except for completion of primary 
education were positively correlated with both anti-
microbial-resistance datasets (appendix).
Total health-care expenditure was strongly and inversely 
 
correlated with both antimicrobial resistance indices; by 
contrast, the ratio of private to public health expenditure 
was strongly and positively correlated. Among measures of 
climate, average temperature was strongly and positively 
correlated with both antimicrobial resistance indices, 
whereas there was a poor correlation with precipitation 
(appendix). For global antibiotic consumption we showed 
Eﬀect on resistance rate 
of 1 SD increase in each 
explanatory variable (logit)
p value
Usage (standardised) 
 
–0·88 
 
0·64
Governance index 
 
–7·89 
 
0·025
Health expenditure index 
 
–5·54 
 
0·093
GDP per capita (standardised) 
 
6·62 
 
0·030
Education index 
 
7·93 
 
0·058
Infrastructure index 
 
–16·84 
 
0·014
Climate index 
 
2·01 
 
0·33
R² 0·54 
 
··
GDP=gross domestic product. R²=coeﬃcient of determination.
Table 2: Escherichia coli Eﬀect of changes in indices on the resistance of to 
third-generation cephalosporins and ﬂuoroquinolones
Eﬀect on resistance rate of 
1 SD increase in each 
explanatory variable (logit)
p value
Usage (standardised) 
 
2·36 
 
0·070
Governance index 
 
–11·18 
 
<0·0001
Health expenditure index 
 
–6·34 
 
0·0065
GDP per capita index 
(standardised)
3·36 
 
0·11
Education index 
 
8·59 
 
0·0035
Infrastructure index 
 
–13·24 
 
0·0052
Climate index 
 
–0·25 
 
0·86
R² 0·75 
 
··
GDP=gross domestic product. R²=coeﬃcient of determination.
Table 3: Eﬀect of changes in indices on the aggregate resistance rate
Figure 1: Global aggregate resistance versus infrastructure and governance
Figure shows levels of aggregate resistance, corruption and governance, and 
= 
 
β j.
100
 
 
resistance
∂xj
resistance. × – 
 
(100 
 
resistance)∂
log =(
(
resistance
resistance
i
i
100 
 
resistance– i
i
β0 
 
+ β1 x1i + ···.. + βkxki + ui
i
 ) 
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Modelled in this manner, the eect of a change in any of 
the explanatory variables was non-linear, and the eect 
infrastructure in orders of severity, from low (ie, low resistance, little corruption, 
and good infrastructure) to high (ie, high resistance, high levels 
 
of corruption, 
and poor infrastructure). 
 
The raw data are available in 
 
the appendix.
Articles
Aggregate resistance
Corruption and governance
Infrastructure
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Low severity 
 
High severity
Articles
a weak inverse relationship with aggregate resistance 
(r=–11%) and a moderate inverse correlation with E coli 
resistance ( =–28%). When the sample included only r
European countries, antibiotic consumption had a strong 
positive correlation with both antimicrobial resistance 
indices ( =62% for aggregate r= 49% 
 
for 
 
E coli resistance, 
 
r
resistance), reﬂecting dierent contagion levels between 
high-income countries and LMICs.
In multivariable regression analysis, an increase of 1 SD 
in the infrastructure index, governance index, and health 
expenditure resulted in signiﬁcant decreases in E coli 
resistance and aggregate resistance ( 2, 3). An tables 
 
increase of 1 SD in education and GDP per person resulted 
in an increase in resistance and aggregate resistance E coli 
(ﬁgure 1, ).appendix
We found no signiﬁcant association between the climate 
 
index and antimicrobial resistance indices. An increase of 
1 SD in the climate index resulted in a non-signiﬁcant 
increase in resistance but a non-signiﬁcant decrease E coli 
in aggregate resistance (table 3). Antibiotic consumption 
was also not signiﬁcantly associated with either anti-
microbial resistance index ( 2). Considering all ﬁgure 
 
covariates, the variation in aggregate resistance was better 
explained by the model than was resistance E coli 
(R² values 0·75 
 
vs 0·54).
Discussion
after adjusting for these three measures, high GDP per 
person and high education levels were also associated 
with higher antimicrobial resistance levels. Also sur-
prising was that antibiotic consumption was not strongly 
associated with antimicrobial resistance levels.
Our model allowed us to quantify the eects of improving 
the indices with the most potential for reducing anti-
microbial resistance. For example, we would see E coli 
 
resistance levels fall by 18 6% for every 1 SD improvement ·
in the infrastructure index. Additionally, we would see a 
 
5·5% decrease in resistance levels if the governance E coli 
index were improved by 1 SD. Undeniably, selection 
pressure due to antibiotic exposure is an important factor 
in the emergence and selection of antimicrobial resistance 
bacterial clones.15,16,18,22  However, our data suggest that 
globally, a high prevalence of antimicrobial resistance can 
be more likely attributed to the dissemination of anti-
microbial resistance, especially via poor sanitation and 
contaminated potable water. This expectation is supported 
by the strong association between the infrastructure index 
and 
 
E coli E coli resistance because are faecal bacteria and 
their presence in water indicates human or animal faecal 
contamination. Aggregate resistance, however, includes 
Klebsiella 
 
spp and , which occupy dierent S aureus
ecological niches. Aggregate resistance results might have 
more accurate associations with the covariates considered 
in our study, because it is supported by better explanation 
of the variation in antimicrobial resistance (with a high R² 
value of 0 54). However, the measure of aggregate 
 
·75 
 
vs 
 
0·
resistance had more data gaps and will need to be 
reassessed when more information, particularly from 
LMICs, becomes available. Poor water quality and sanita-
tion have been linked with many poor health outcomes, so 
seeing their association with high levels of antimicrobial 
resistance is no surprise.26,27
Other infrastructure measures, such as urbanisation, 
internet accessibility, and access to electricity, were all 
strongly associated with lower antimicrobial resistance 
rates. However, these factors might be not directly linked 
to lower antimicrobial resistance levels but rather 
indicative of better sanitation, access to clean water, and 
access to refrigeration. It is notable that the higher the 
public health-care expenditure, the lower the aggregate 
resistance. Conversely, a higher proportion of private 
health-care spending was associated with higher levels of 
antimicrobial resistance, as was also shown in a previous 
study comparing only data across Europe.22 In Brazil, the 
density of private health clinics was associated with 
higher antibiotic consumption,28  an eect that might 
reﬂect the regulatory environment—ie, private clinics 
might follow public health rules and guidelines less 
often, or regulators with oversight might not restrict the 
Figure 2: Escherichia coli resistance levels for ﬂuoroquinolones and third-generation cephalosporins compared 
with antibiotic consumption
Figure shows data for percentage of resistance versus 
 
deﬁned daily 
 
dose (DDD) of antibiotic, plotted only for 
countries with data for DDD and both measures 
 
of resistance. Blue circles indicate Escherichia coli resistance to 
third-generation cephalosporins (%). Red circles indicate resistance to ﬂuoroquinolones (%). 
 
The blue line E coli 
shows the linear measure 
 
of resistance to third-generation cephalosporins. The red line shows the linear E coli 
measure of ²=coeﬃcient of determination.E coli 
 
resistance to third-generation 
 
ﬂuoroquinolones. R
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Discussion
Our results indicated that poorer infrastructure (eg, poor 
sanitation) and poorer governance (eg, corruption) were 
consistently associated with higher levels of antimicrobial 
resistance. Low health expenditure was also associated 
with higher levels of antimicrobial resistance. Surprisingly, 
often, or regulators with oversight might not restrict the 
types and quantities of antibiotics used in these clinics. 
These data have substantial ramiﬁcations for public 
health spending in regions like Africa and south Asia.
Counterintuitively, higher education was signiﬁcantly 
associated with increased levels of antimicrobial resistance. 
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In certain LMICs, more auent and better educated 
people have better access to antibiotics and use more 
antibiotics.28 Our data also indicated that higher education 
was correlated with high antibiotic consumption. Thus, 
perversely, although higher levels of education have 
many associated beneﬁts, educated people in LMICs 
might be contributing more to the burden of antimicrobial 
resistance. Unsurprisingly, therefore, higher GDP per 
person was associated with higher antimicrobial res-
istance; however, this was not signiﬁcant with aggregate 
resistance in the multivariable analysis. Countries with 
high GDP per person are known to have high antibiotic 
usage.11  Any beneﬁcial eects of higher GDP on anti-
microbial resistance might already be captured by more 
directly relevant variables such as infrastructure and 
health expenditure. Poverty itself might not have a direct 
eect on levels of antimicrobial resistance, but this will be 
aected by factors such as access to sanitation, clean water, 
and electricity.
There was a univariate correlation with temperature 
and antimicrobial resistance: the warmer the country, 
the higher its antimicrobial resistance levels. This 
correlation might, however, be biased; some cold coun-
tries with very good governance and social support 
(eg, Scandinavian countries and Canada) have low 
antimicrobial resistance levels, whereas Russia is sim-
ilarly cold but has antimicrobial resistance levels higher 
than most other countries (perhaps correlating with 
poor governance and corruption). The correlation with 
temperature is an interesting ﬁnding, but whether this is 
a socioeconomic factor (poorer infrastructure in hotter 
areas) or has to do with temperature per se remains 
unclear. However, in some environments (eg, waterways), 
warm temperatures oer more potential for bacteria to 
multiply and transfer antimicrobial resistance genes 
at high frequencies. Warmer temperatures are also 
associated with higher insect populations, which have 
played a part in disseminating resistant bacteria.6,29  Data 
on national climate (average temperature and rainfall) 
did not have a signiﬁcant correlation with antimicrobial 
resistance but might not capture climatic variations that 
occur within even some reasonably small countries. 
More detailed analysis examining the eect of climate 
will require subnational data. Precipitation had a weaker 
correlation than did temperature; however, precipitation 
might not be a reliable indicator of ﬂooding, which 
can spread antimicrobial resistance bacteria throughout 
communities.
Corruption levels in countries are strongly correlated 
with high levels of antimicrobial resistance, a result that 
corruption on antimicrobial resistance levels are however 
likely to be indirect.22
Surprisingly, we found that antibiotic consumption 
was poorly correlated with antimicrobial resistance 
levels. This was also true when we analysed our res-
istance indices against older published consumption 
data.23  Whereas developed regions, such as Europe, 
showed a correlation between antimicrobial resistance 
levels and antibiotic usage, this was not evident from the 
global data. A possible explanation is that antibiotic 
volumes are not a factor until a country reaches a 
medium or high level of social and economic develop-
ment. More importantly, other factors such as water 
quality and sanitation levels are likely to have a greater 
eect than antibiotic consumption volumes. This is an 
important issue for countries where large groups of 
people have trouble accessing antibiotics. Our data 
suggest that the relationship between antibiotic con-
sumption and population resistance levels varies across 
the world.
Our study and our model have several limitations, many 
of which are also acknowledged in greater detail in other 
studies.11,15,17  First, many countries still have incomplete or 
missing data (especially data for antibiotic consumption), 
which limited the number of countries included in the 
multivariable analysis. Second, some additional factors 
that might correlate with antimicrobial resistance levels 
could not be measured—eg, insects, even though they are 
aected by temperature and precipitation. Third, our 
aggregate resistance measure included E coli, 
 
spp, Klebsiella 
 
and 
 
S aureus, which occupy dierent environmental 
niches and will be aected by dierent demographic 
factors. Fourth, although we used the best global resistance 
data available, country data were not consistently deﬁned 
with regard to community and hospital coverage, nor 
for the numbers of samples or bacteria reported. The 
resistance data might be an underestimation or over-
estimation in the absence of robust, representative 
surveillance systems, particularly in LMICs. We also 
 
might not have captured data from all contemporary 
publications on . Fifth, our data did not capture the E coli
number of antibiotics purchased through the internet; 
such sales are rapidly growing and volumes remain 
unknown, and consumption data might be an under-
estimation because they might not have included data 
about antibiotic donations or exposure as a result of mass 
antibiotic-administration campaigns in LMICs. Sixth, 
there might have been a lag period between antibiotic 
consumption and emergence of antibiotic resistance. 
Finally, we did not obtain comprehensive data on 
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conﬁrms previous ﬁndings in Europe.
22
 Rule of law was 
better correlated with antimicrobial resistance levels 
than corruption levels, but in our dataset, available 
data were predominantly from European and developed 
countries. Accordingly, in view of these data gaps, 
rule of law is currently a less reliable global indicator 
of governance than corruption indexes. The eects of 
antimicrobial use in food animals, which might account 
for more than 70% of total antimicrobial usage and is 
especially high in LMIC countries.30
To our knowledge, this was the ﬁrst study to examine 
how several factors aect antimicrobial resistance at 
the global level. We used a more comprehensive dataset 
 
than have previously published studies,10,11,15,17,18,22,23,28  and 
Articles
analysed several socioeconomic factors in addition to anti-
biotic consumption and antimicrobial resistance levels. 
Our ﬁndings have major policy implications. In developed 
countries, where the focus has been on antibiotic con-
sumption as the most identiﬁable factor contributing to 
antimicrobial resistance, we showed that consumption 
explains only a portion of the observed antimicrobial 
resistance levels. Moreover, intervention measures to 
decrease antibiotic consumption alone are not likely to 
be sucient, especially in LMICs, because contagion is 
probably the main factor aecting antimicrobial resis-
tance levels. Simultaneous measures to improve 
 
san-
itation, infection control and prevention, access to clean 
water, governance, and public expenditure on health-care 
need to be implemented to tackle antimicrobial resistance 
on a global scale.
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